Fiche publication
Date publication
juillet 2021
Journal
Journal for immunotherapy of cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ADOTEVI Olivier
,
Dr BOIDOT Romain
,
Dr MIRJOLET Céline
,
Dr BOUSTANI Jihane
Tous les auteurs :
Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, Marguier A, Tochet F, Dosset M, Boustani J, Ravel P, Boidot R, Spehner L, Haicheur-Adjouri N, Marliot F, Pallandre JR, Bonnefoy F, Scripcariu V, Van den Eynde M, Cornillot E, Mirjolet C, Pages F, Adotevi O
Lien Pubmed
Résumé
Multiple synergistic combination approaches with cancer drugs are developed to overcome primary resistance to immunotherapy; however, the mechanistic rationale to combine chemoradiotherapy (CRT) with immune checkpoint inhibitors remains elusive.
Mots clés
adaptive immunity, combination, drug therapy, immunotherapy, radiotherapy, tumor microenvironment
Référence
J Immunother Cancer. 2021 Jul;9(7):
